MAITREYA MEDICARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 138 INR | -0.40% |
|
+6.15% | +12.56% |
| 06-07 | Maitreya Medicare Limited Partners with Prannath Hospital | CI |
| 05-28 | Maitreya Medicare Limited Appoints Chandan Chetnani as Company Secretary and Compliance Officer | CI |
| Sales 2022 | 494M 5.92M 8.07M | Sales 2023 | 394M 4.72M 6.43M | Capitalization | 935M 11.2M 15.28M |
|---|---|---|---|---|---|
| Net income 2022 | 11M 132K 180K | Net income 2023 | 42M 503K 686K | EV / Sales 2022 * | - |
| Net cash position 2022 * | - 0 0 | Net cash position 2023 * | - 0 0 | EV / Sales 2023 * | - |
| P/E ratio 2022 * |
-
| P/E ratio 2023 * |
-
| Employees | - |
| Yield 2022 * |
-
| Yield 2023 * |
-
| Free-Float | 99% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.40% | ||
| 1 week | +6.15% | ||
| Current month | +6.15% | ||
| 1 month | +4.70% | ||
| 3 months | -7.20% | ||
| 6 months | -6.57% | ||
| Current year | +12.56% |
1 week
135.85
144.00
1 month
126.00144.00
Current year
118.55229.45
1 year
113.90229.45
3 years
113.90229.45
5 years
113.90229.45
10 years
113.90229.45
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-05 | 138 | -0.40% | 4,800 |
| 24-07-04 | 138.6 | -3.11% | 14,400 |
| 24-07-03 | 143 | -0.21% | 15,200 |
| 24-07-02 | 143.3 | +4.98% | 10,400 |
| 24-07-01 | 136.5 | +5.00% | 24,000 |
Delayed Quote NSE India S.E., July 05, 2024 at 07:40 am
More quotes
Maitreya Medicare Limited is an India-based company, which operates a 125 bedded, multispecialty hospital. It provides multi-disciplinary integrated healthcare services, with a focus on primary secondary and tertiary care. It offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including cardiology, urology, oncology, laparoscopic surgery, neurology, neurosurgery, spine surgery, nephrology, including dialysis, gastroenterology, gastrointestinal surgery, cardiothoracic surgery, oncosurgery, orthopedic surgery, including joint replacements and arthroscopic surgeries, gynecology and high-risk obstetrics, hepatocellular billary surgery, and critical care medicine, among others. The Company's facility consists of a Cath lab with Ivus/FFR/Rota and 20-bed Intensive Care Unit (ICU) fully equipped with ECMO/CRRT ventilators and monitors. The company's subsidiaries include Maitreya Hospital Private Limited and Maitreya Lifescience Private Limited.
| 1st Jan change | Capi. | |
|---|---|---|
| +12.56% | 11.2M | |
| +18.33% | 83.89B | |
| -28.29% | 71.08B | |
| +0.07% | 26.77B | |
| +3.67% | 17.74B | |
| -9.99% | 17.24B | |
| +1.86% | 15.6B | |
| +79.98% | 13.84B | |
| -25.09% | 12.92B | |
| +74.41% | 12.87B |
- Stock Market
- Equities
- MAITREYA Stock
